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Differential Effects of IL-2 and IL-6 on the Development of
Three Distinct Precursor T-Cell Populations in the Thymus
NAOKO NAKANO, HITOSHI KIKUTANI, and TADAMITSU KISHIMOTO
Division of Immunology, Institute for Molecular and Cellular Biology, Osaka University, 1-3, Yamada-Oka, Suita City, Osaka 565, Japan
Three distinct T-cell precursors: bone marrow cells that express low levels of the Thy-1
antigen but no lineage markers (Thy-l-lo/BM); CD4-, CD8-, and CD3- thymocytes that
express low levels of the Thy-1 antigen (Thy-l-lo/Thym); and CD4-, CD8-, and CD3-
thymocytes that express high levels of the Thy-1 antigen and the IL-2 R cz chain (Thy-1 //
IL2R /) were isolated by fluorescence-activated cell sorter (FACS). These three populations
expanded with different kinetics in the thymus of irradiated recipient mice after intrathymic
transfer. When a high dose of human recombinant IL-2 (r-IL-2) or human recombinant IL-6
(r-IL-6) was administered, r-IL-6 accelerated donor Thy-1 +/IL2R to differentiate, whereas
r-IL-2 blocked normal differentiation and expansion of donor Thy-l-lo/Thym, but did not
show any significant effect on donor Thy-1 //IL2R /. Neither r-IL-2 nor r-IL-6 worked directly
on donor Thy-lalo/BM in this transfer system.
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INTRODUCTION
Development of T cells in the thymus can be
divided into two major processes: early T-cell
development before the acquirement of T-cell-
receptor (TCR) expression and TCR-mediated matu-
ration of T cells such as "positive" and "negative"
selections. Early events of TCR-independent T-cell
development are further characterized by (1) com-
mitment of stem cells to T-cell lineage, presumably
in the bone, marrow, (2) migration of precursor T
cells into the thymus, and (3) rearrangement of TCR
genes before expressing CD4/CD8 differentiation
antigens. All of these processes are essential to pro-
vide progenitor cells that are to be selected within
the thymus and eventually cover all the T-cell reper-
,toire required.
Recently, a number of studies have been carried
out to fractionate CD4-/CD8- (double-negative)
thymocytes on the basis of cell-surface phenotypes,
such as Thy-1, Ly-1, Pgp-1, interleukin-2 receptor
(IL-2R), J11d, and B2A2 (Ceredig et al., 1985;
Fowlkes et al., 1985; Raulet, 1985; Husman et al.,
1988; Scollay and Shortman, 1985; Rearse et al.,
1989). Previously, we identified the most immature
double-negative thymocyte population that lacks IL-
2R and CD3 expression, but expresses low levels of
the Thy-1 antigen (Nakano et al., 1987). These cells
reconstituted T cells in irradiated host mice when
they were transferred intravenously. There is also a
distinct population of double-negative thymocytes
that expresses high levels of Thy-1 and IL-2R, and is
known to give rise to mature thymocytes efficiently
when they are injected into the thymus directly
(Shimonkevitz et al., 1987). It has been demon-
strated that purified stem cells from the bone
marrow have a potential to give rise to T cells when
they are injected intrathymically. Such cells lack dif-
ferentiation markers such as T cells, B cells, macro-
phages, and granulocytes, but express the Sca-1
antigen and low levels of the Thy-1 antigen
(Spangrude et al., 1988). Although precursors in the
thymus and in the bone marrow are apparently dif-
ferent, it is still obscure in what stage of differentia-
tion they are and what kind of growth factors are
required for their expansion and differentiation.
IL-2 induces proliferation of activated T cells.
However, it is not clear how IL-2 is involved in
T-cell ontogeny, although a certain population of
thymocytes are known to express the c chain of IL-
2R. Recently, one of the pleiotropic factors, inter-
leukin-6 (IL-6) (Hirano and Kishimoto, 1990), also
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has been reported to work as a T-cell growth factor
(Le et al., 1988; Uttenhove et al., 1988), and it is
possible that IL-6 plays a role in thymocyte develop-
ment.
In an attempt to understand the differentiation
process of precursor T cells, we took advantage of
intrathymic injection (Goldschneider et al., 1986),
combining with the three-color fluorescence-acti-
vated cell sorter (FACS) to isolate distinct T-cell pre-
cursors and to chase the fate of only donor-derived
thymocytes in the host thymus. Effects of IL-2 and
IL-6 on the development of T cells were also studied
in this experimental system by administration of a
relatively large amount of human recombinant IL-2
(r-IL-2) or human recombinant IL-6 (r-IL-6) to reci-
pient mice that had been injected with sorted pre- B
cursor T cells.
RESULTS
Capacity of Expansion and the Stage of
Development of Precursor T Cells
On the basis of Thy-1 and IL-2-R expression,
double-negative and CD3-negative C3H/HeN
thymocytes were subfractionated into three popu-
lations, IL-2-R
/ and IL-2-R- thymocytes (Thy-l+/
IL2R
/ and Thy-I//IL2R -, respectively), both of
which express high levels of the Thy-1 antigen, and
thymocytes with low levels of the Thy-1 antigen
(Thy-l-lo/Thym) (Nakano et al., 1987). Bone marrow
cells expressing low levels of the Thy-1 antigen
(Thy-l-lo/BM), which have been demonstrated to
give rise to T cells as well as all lineages of hemato-
poietic cells (Muller-Sieburg et al., 1986), were also
sorted from C3H/HeN bone marrow cells as another
source of precursor T cells. Sorted precursor T-cell
populations were intrathymically injected into sub-
lethally irradiated AKR/J recipients and examined
for their ability to reconstitute the recipient thy-
muses.
T cells derived from injected precursor cells were
chased by staining the Thy-l.2 antigen, which
allows distinguishing T cells of donor origin from
those of host AKR/J (Thy-l.1), and Fig. 1A shows
kinetics of expansion of donor-derived T cells
detected as Thy-l.2 /. When I xl06 Thy-I//IL2R
were injected, cells detectable as Thy-l.2
/ tapered
off within a few days and did not expand in the
thymuses of irradiated recipients. In the recipient
thymuses injected with 2x10 Thy-I+/IL2R
/ cells,
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FIGURE 1. (A) Expansion of donor precursor T cells in the
thymus after intrathymic injection. Either 2x104 Thy-l-lo/BM
(closed circle), I xl05 Thy-l-lo/Thym (open square), 2 xl05 Thy-
I+/IL2R (open circle), or I xl06 Thy-I+/IL2R (closed square)
from C3H/HeN (Thy-l.2) was injected intrathymically into
sublethally (690 rad) irradiated AKR/J (Thy-l.1) mice. Thymocytes
prepared from the recipient mice were analyzed by FACS 440 on
the day indicated. Mean values of numbers of Thy-l.2 cells in
two to three different transfers were shown. Each cell number
was calculated from the total number, of thymocytes and the
percentage of Thy-l.2-positive cells. (B) Expression of CD4 and
CD8 on donor type (Thy-l.2 +) thymocytes in recipient thymuses
injected with either (a) Thy-I+/IL2R +, (b) Thy-l-lo/Thym, or (c)
Thy-l-lo/BM. Thymocytes were prepared at indicated time points
after the transfer of each precursor population, and stained with
FITC-anti-CD8, PE-anti-CD4, and PC-anti-Thy-l.2 except for the
right panel in (C), where PC-anti-CD4 and PE-anti-Thy-l.2 were
used with FITC-anti-CD8.IL-2 AND IL-6 ON T PROGENITORS 79
Thy-l.2
/ donor-derived cells expanded one
hundredfold within 10-14 days and decreased there-
after. T cells derived from this precursor population
were mostly CD4+/CD8
/ on day 11, and gradually
shiftedtoward CD4//CD8- and CD4-/CD8
/ on day
18, Fig. 1B(a). A delay in expansion of donor-
derived thymocytes was observed when I xl0 Thy-
1-1o/Thym was injected. Although cells detected as
Thy-l.2
/ expressed mostly both CD4 and CD8 on
day 12, their cell number was only tenfold higher
than that of injected cells, Fig. 1A and Fig. 1B(b).
They continued to expand and reached the
maximum level on day 21 with one hundredfold
expansion. As shown in Fig. 1B(b), the differentiated
cells such as single positive cells were observed on
day 21. The delay of progression and expansion
indicates that Thy-l-lo/Thym is a more immature
population.
It took much longer for Thy-l-lo/BM to dif-
ferentiate into double positive. Cells detected as
Thy-l.2
/ were still double negative 11 days after
injection of 2x104 Thy-l-lo/BM (data not shown).
However, Thy-l.2
/ cells were composed of double-
positive cells on day 18, as shown in Fig. 1B(c).
Thy-l-lo/BM-derived cells increased sharply after 14
days and occupied almost the whole thymus one
month later. In contrast to Thy-I+/IL2R
/ and Thy-1-
lo/Thym, which could transiently reconstitute the
thymus, Thy-l-lo/BM had a potential to expand 10
thousandfold (Fig. 1A) and this state continued over
2 months. When cells were analyzed 38 days later,
half of the thymocytes were still of donor type (Thy-
1.2 +) and their phenotypes shown in Fig. 1B(c) were
similar to those in normal mice.
In this system, the kinetics and the extent of
expansion and differentiation appear to indicate the
differentiation stage of precursor T cells; Thy-l//
IL2R- is the most differentiated population because
of its incapability of expansion, and Thy-I+/IL2R
/ is
more differentiated than Thy-l-lo/Thym, which was
indicated by its delayed kinetics of thymus reconsti-
tution. Thy-l-lo/BM differs completely from Thy-1-
lo/Thym in terms of capacity of expansion and
duration of reconstitution, although its phenotype is
similar to Thy-l-lo/Thym.
IL-6 Promotes Thy-I+/IL2R+ to Differentiate into
CD4+/CD8+ and CD4+/CD8
We enployed this transfer system to investigate the
effects of r-IL-2 and r-IL-6 on the reconstitution of
the thymus by three T-progenitor populations: Thy-
I//IL2R +, Thy-l-lo/Thym, and Thy-l-lo/BM, all of
which were capable to expand in the thymus, as
described before. First, irradiated AKR/J recipients
were intrathymically transferred with Thy-I//IL2R +
C3H/HeN cells and then injected with saline, 10g
of r-IL-2, or 10g of r-lL-6 every day. By gating on
donor-derived Thy-l.2 positive cells, the expression
of CD4 and CD8 on the donor-derived thymocytes
was analyzed on day 11. As shown in Fig. 2A,
surface phenotypes of donor-derived cells were
mostly CD4+/CD8
/ at this point. The relative pro-
portion of CD4-/CD8-cells in r-IL-6-treated mice
was lower than in the control, Fig. 2A(c). The abso-
lute number of donor-derived cells in r-IL-6-treated
recipient thymus was found to be several times
higher than that in the control. This difference was
much evident in CD4+/CD8
/ and CD4//CD8-
populations (Table 1, Exp. 1 and 2). On day 14, on
the contrary, donor-derived cells were less in r-IL-6o
treated mice than in control mice (Table 1, Exp. 3).
This result suggests that r-IL-6 may accelerate the
differentiation from Thy-I+/IL2R
/ cells to CD4//
CD8
/ cells. A little or no increase of donor-derived
cells was observed in r-IL-2-treated mice in Table 1,
althrough these cells expressed the cz chain of IL-2R.
IL-2 Blocks Normal Differentiation of
Thy-l-lo/Thym
Thy-l-lo/Thym was similarly injected into the
thymus of irradiated recipients and 10/g of either
r-IL-2 or r-IL-6 were administered every day. On
day 14, mice were sacrificed and CD4 and CD8
expressions of Thy-l.2
/ donor-derived thymocytes
were analyzed. Although phenotypes of thymocytes
in r-IL-6-treated recipients were similar to those in
saline-treated controls, Fig. 2B(a) and (c), more
progeny derived from Thy-l-lo/Thym was detected
in r-IL-6-treated mice than in controls on day 14
(Table 2, Exp. 1), then less on day 18 (Table 2, Exp.
3). We suppose Thy-l-lo/Thym passes though the
Thy-I+/IL2R
/ stage (data not shown), so that the
effect obtained by r-IL-6 on Thy-l-lo/Thym may
have been exerted on that stage.
In contrast, r-IL-2 treatment caused a dramatic
effect on the expansion and differentiation of Thy-1-
lo/Thym. Their phenotypes turned out more wide-
spread. The relative proportions of single-positive
cells and double-negative cells increased in r-IL2-
treated mice, whereas that of double-positive cells
decreased, as shown in Fig. 2B(b). Interestingly,
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FIGURE 2. Effects of r-IL-2 and
r-IL-6 on the development of donor-
derived thymocytes. (A) I xl0 Thy-
1VIL2R/, (B) I xl0 Thy-l-lo/Thym,
or (C) lx104 Thy-l-lo/BM isolated
from C3H/HeN mice were transferred
intrathymically into irradiated AKR/J
mice as mentioned in Figure 1. Either
(a) saline, (b) 10g r-IL-2, or tc)
10/zg r-IL-6 was administered daily.
Thymocytes were analyzed on (A)
day 11, (B) day 14, or (C) day 15,
staining with FITC-anti-CD8, PC-anti-
CD4, and PE-anti-Thy-l.2. Profiles of
cells gated positively on Thy-l.2 were
shown.
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TABLE 1
The Effect of r-IL-2 and r-IL-6 on the Reconstitution of the Thymus with Thy-I//IL2R Cells
Donor type cells in the thymus xl0 -5)
Days after Treated
transfer with Total CD4-CD8- CD4/CD8 CD4/CD8- CD4-CD8
1 11 Saline 7.3 0.21 6.8 0.20 0.059
r-IL-2 6.3 0.19 5.9 0.11 0.075
r-IL-6 46 0.27 44 1.7 0.15
2 11 Saline 3.1 0.48 2.5 0.11 0.012
r-IL-2 13 0.49 12 0.46 0.047
r-IL-6 34 0.65 32 1.3 0.038
3 14 Saline 190 0.57 172 17 1.2
r-IL-2 192 0.50 177 13 1.0
r-IL-6 81 0.26 71 8.5 0.85
al Xl0 Thy-I//IL2R cells sorted from C3H/HeN (Thy-l.2) were injected intrathymically into 690-rad irradiated AKR/J (Thy-l.1) mice. Human r-IL-2
(10 #g), r-IL-6 (10/g), or saline was administered to the recipients once a day until the day before the analysis. Numbers of donor-derived cells (Thy-l.2 /)
were calculated from the number of total thymocytes in the recipient mouse and the data of the three-color FACS analysis.IL-2 AND IL-6 ON T PROGENITORS 81
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TABLE 2
The Effect of r-IL-2 and r-IL-6 on the Reconstitution of the Thymus with Thy-l-lo/Thym Cells
Donor type cells in the thymus xl0 -5)
Days after Treated
transfer with Total CD4-CD8- CD4/CD8 CD4/CD8- CD4-CD8
1 14 Saline 21 0.97 19 1.0 0.50
r-IL-2 2.7 0.59 1.5 0.44 0.16
r-IL-6 70 3.1 59 6.5 1.2
2 14 Saline 23 1.1 19 1.3 0.31
r-IL-2 0.86 0.22 0.40 0.044 0.20
r-IL-6 29 1.3 25 2.2 0.34
3 18 Saline 23 1.1 20 1.4 0.31
r-IL-2 0.33 0.17 0.13 0.013 0.018
r-IL-6 4.4 1.0 2.7 0.40 0.29
alxl0s Thy-l-lo/Thym cells from C3H/HeN were injected intrathymically into irradiated AKR/J (Thy-l.1) recipients. The other procedures were
described in the footnote for Table 1.
Exp.
TABLE 3
The Effect of r-IL-2 and r-IL-6 on the Reconstitution of the Thymus with Thy-l-lo/BM Cells
Donor Type cells in the thymus xl0 -5)
Days after Treated
transfer with Total CD4-CD8- CD4/CD8 CD4/CD8- CD4-CD8
1 15
2 15
Saline 104 6.1 89 6.2 2.3
r-IL-2 48 3.0 40 2.8 2.2
r-IL-6 173 16 139 12 6.2
Saline 107 3.2 94 8.8 0.66
r-IL-2 37 0.32 34 2.3 0.11
r-IL-6 108 1.6 96 9.6 0.49
al xl04 Thy-l-lo/BM cells were transferred intrathymically into irradiated recipient mice. The other procedures were described in the footnote for
Table 1.
CD4+/CD8
/ and CD4+/CD8-, were reduced
extremely in r-IL-2-treated mice (Table 2). This
result indicates that r-IL-2 interferes with the expan-
sion and differentiation of Thy-l-lo/Thym.
Thy-l-lo/BM Cells as Precursor T Cells Are Not
Sensitive to Either r-IL-2 or r-IL-6
Irradiated AKR/J mice were injected intrathymically
with I xl04 Thy-l-lo/BM cells and administered with
r-IL-2, r-IL-6, or saline every day. Phenotypes of
donor-derived cells in the recipient thymuses were
analyzed as in other transfers. On day 15, as shown
in Fig. 2C(a), the main population of transferred
cells was double positive and phenotypic patterns of
thymocytes were almost identical among three treat-
ments.(Fig. 2C). We did not find any clear effect of
r-IL-6 on the expansion of progeny of Thy-l-lo/BM
cells, as shown in Table 3. Some reduction of cell
numbers in r-IL-2-treated mice was observed,
possibly because. Thy-l-lo/BM differentiated into the
stage of Thy-l-lo/Thym, where r-IL-2 blocked the
differentiation.
DISCUSSION
We isolated three subpopulations of double-negative
and CD3-negative thymocytes as well as T pro-
genitors from bone marrow cells and examined their
growth and differentiation in the thymus. Thy-l+/
IL2R-, which had been previously shown to directly
differentiate into double-positive cells in an in vitro
culture (Nakano et al., 1987), failed to expand in the
thymus (Fig. 1A) and was considered as the most
differentiated population in double-negative/CD3-
thyrnocytes. Both Thy-I+/IL2R + and Thy-l-lo/Thym
populations could expand and transiently reconsti-
tute the recipient thymuses. However, the kinetics
of the expansion of these two populations was dif-
ferent. The peak of expansion of Thy-I+/IL2R
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observed on day 14, whereas the number of progeny
of Thy-l-lo/Thym population was maximum on day
21 and then decreased. This observation suggests
that Thy-l-lo/Thym may be more immature than
Thy-I+/IL2R+ and coincides with our previous
results obtained by intravenous transfer and in vitro
culture (Nakano et al., 1987). In the previous experi-
ment (Nakano et al., 1987), Thy-I+/IL2R
/ cells failed
to reconstitute the thymus when transferred intra-
venously. This may be due to the difference of the
route of the transfer or the timing of analysis.
Similar subfractionations of immature thymocytes
on the basis of the IL-2R cz-chain expression have
been reported. Shimonkevitz et al. (1987) divided
double-negative thymocytes into two subpopula-
tions, IL-2R
/ and IL-2R- cells, and showed that IL-
2R
/ cells had more capacity to reconstitute the
thymus by using intrathymic injection. Recently,
Rearse et al. (i989) fractionated double-negative
thymocytes by using two markers, Pgp-1 and IL-2R,
and .demonstrated that the differentiation sequence
of immature thymocytes was Pgp-I//IL2R---* Pgp-
I//IL2R /’-* Pgp-1-/IL2R-. The present study showed
that the IL-2R+ population in double-negative
thymocytes was at an intermediate stage between
Thy-l-lo/Thym and Thy-I+/IL2R -. If we assume
that Thy-l-lo/Thym cells express the Pgp-1 antigen,
their results may be consistent with ours.
The reconstitution by Thy-l-lo/BM cells lasted for
at least 2 months (data not shown) in contrast to the
transient reconstitution by Thy-l-lo/Thym and Thy-
I+/IL2R /. A similar observation was obtained by
Katsura et al. (1988) from their intrathymic transfer
experiments using unfractionated cells from thymus,
bone marrow (BM), and spleen as a source of T-cell
progenitors. These findings suggest that precursors
in the thymus have a poor self-renewal activity
compared to those in BM. However, it is likely that
Thyol-lo/BM still includes hematopoietic progenitors
of different stages such as Thy-l-lo/Sca-1
/ pluri-
potent stem cells (Spangrude et al., 1988). Therefore,
there are two possibilities: (1) pluripotent hemato-
poietic stem cells, which have self-renewal activity,
may participate in the expansion and differentiation
exclusively to T-cell lineage in the thymus, or (2) a
certain progenitor population in Thy-l-lo/BM, which
is already committed to T lineage, but more
immature than Thy-l-lo/Thym, may be the cells
responsible for the reconstitution of the thymus. In
fact, it was reported that Thy-l-lo/Sca-1 + pluri-
potent stem cells could reconstitute the thymus
when they were transferred intrathymically (Spang-
rude et al., 1988). This favors the former possibility.
Whichever is the case, Thy-l-lo/BM differs com-
pletely from Thy-l-lo/Thym in terms of reconstitu-
tion of the thymus.
Progenitor T cells homed in the thymus pro-
liferate and differentiate under the influence of the
microenvironment in the thymus. The intrathymic
transfer system is thus useful for the analysis of the
effect of growth factors on precursor cells devel-
oping in concert with the thymic environment. This
study demonstrated that r-IL-2 and r-IL-6 exerted
their effect on different stages of precursor T cells.
r-IL-6 was found to work preferentially on Thy-l//
IL2R +, resulting in the acceleration of thymus recon-
stitution by this population. Previously, r-IL-6 was
shown to enhance hematopoietic activity of bone
marrow cells (Ikebuchi et al., 1987; Koike et al.,
1988). In our system, however, r-IL-6 showed little
effect on the reconstitution with Thy-l-lo/BM. One
may argue that r-IL-6 should have some effect on
the expansion and differentiation of Thy-l-lo/Thym
or Thy-l-lo/BM, since these cells pass through the
Thy-I+/IL2R
/ stage on the process of differentiation.
In fact, the treatment with r-IL-6 sometimes
enhanced the expansion of Thy-l-lo/Thym; we
observed 2 to 3 times more progeny of Thy-l-lo/
Thym in r-IL-6-treated mouse in Exp. 1 of Table 2.
The administration of r-IL-2 to the recipient mice
that were transferred with Thy-l-lo/Thym caused a
dramatic reduction of the donor-derived cells both
on day 14 and day 18. There are two possibilities:
(1) IL-2 blocked the growth and differentiation of
Thy-l-lo/Thym or (2) r-IL-2 accelerated the differen-
tiation of Thy-l-lo/Thym. If the latter is the case, we
should have seen Thy-l.2
/ T cells in the periphery.
However, we did not detect those cells in lymph
nodes (data not shown). Although the absolute
number of donor-derived thymocytes decreased, the
relative ratio of CD4+/CD8 -, CD4-/CD8 /, and
CD4-/CD8-cells derived from transferred Thy-l-lo/
Thym increased in the thymus of r-IL-2-treated reci-
pients. There are two possibilities: (1) the dose of
r-IL-2 was not sufficient for the inhibition of all
Thy-l-lo/Thym, resulting in the development of
some cells normally, or (2) Thy-l-lo/Thym may be
still heterogeneous with regards to the sensitivity to
r-IL-2. Interestingly, Thy-l-lo/Thym cells do not
express the IL-2R cz chain. The inhibitory effect of
IL-2 might be exerted through the IL-2R 15 chain.
Since NK cells were shown to express the/J chain of
IL-2R (Shimonkevitz et al., 1987), it may be reason-
able to assume its presence in Thy-l-lo/Thym. InIL-2 AND IL-6 ON T PROGENITORS 83
vitro isolated IL-2R
/ double-negative thymocytes Then these cells were stained with FITC-labeled
were .reported not to be responsive to IL-2 (von anti-CD4 and FITC-anti-CD8, bi-anti-IL-2R and
Boehmer et al., 1985), but responsive with additional phycocyanin (PC)-anti-Thyl.2, followed by phyco-
stimuli like PMA plus ionomycine (Lowenthal et al., erythrin (PE)-avidin for IL-2R
/ cell sorting. All
1986). Jenkinson et al. (1987) and Tentori et al. double-negative IL-2R
/ thymocytes were Thy-1 /,
(1988) showed that anti-IL-2R cz-chain antibodies and 30-40% of double-negative thymocytes
blocked the generation of mature T cells in thymic belonged to this fraction. This fraction was used as
organ culture as well as in vivo, demonstrating an Thy-I+/IL2R /. To obtain Thy-l-lo/Thym, double-
importance of IL-2-IL-2R interaction in thymocyte negative thymocytes enriched as described before
differentiation. Effects of IL-2 on the development of were stained with FITC-anti-CD4, FITC-anti-CD8,
precursor T cells have been suggested (Toribio et al., PE-anti-Thy.l.2, and PC-anti-CD3, and cells
1988). However, in the present study, exogenously expressing low levels of Thy-l.2 but lacking CD3
administered IL-2 did not show much effect on this expression among double-negative thymocytes were
distinct Thy-I+/IL2R
/ stage, although a small sorted. Bone marrow cells were prepared from
increase of donor-derived cells was occasionally femurs and tibias of 3-5-week-old C3H/HeN mice.
observed (Table 1. Exp. 2). The controversy might be Hemolyzed bone marrow cells were stained with
explained by assuming that endogenously generated FITC-anti-B220, FITC-anti-Mac-1, FITC-53-10.1,
IL-2 might be sufficient for the development of Thy- FITC-anti-CD4, FITC-anti-CD8, and PC-anti-Thy-
I//IL2R+ cells. The antibodies against the human ] 1.2. Cells expressing low levels of Thy-1 and not
chain of IL-2R as well as the human IL-6R are now detectable for FITC stainings were sorted. This
available (Hirata et al., 1989; Takeshita et al., 1989). population was approximately 0.5% of total bone
Therefore, reagents against murine counterparts of marrow cells and used as Thy-l-lo/BM. All the
them will enable us to do more detailed studies on sorting and analysis were done with FACS 440 dual-
the role of these growth factors on T-cell matura- laser dye-laser cell sorter (Becton Dickinson,
tion. Mountain View, CA).
MATERIALS AND METHODS Precursor-Cell Transfer and Analysis
Antibodies Sorted precursor populations from C3H/HeN mice
(Thy-l.2) were resuspended in Hanks’ balanced salt
Monoclonal antibodies (mAbs) were purified from solution and injected intrathymically into 7-10
culture supernatants of hybridomas 53-6.7 (anti- week-old female AKR/J mice (Thy-l.1) that had
CD8) (Ledbetter et al., 1982), GK-1.5 (anti-CD4) been y-irradiated (690 rad). Methods of injection
(Dialynas et al., 1983), 53-7.3 (anti-CDS), MAR18.5 were described previously (Goldschneider et al:,
(mouse anti-rat Ig:), 30H12 (anti-Thyl.2) (Ledbetter 1986). For the analysis of donor-derived cells,
et al., 1979), PC61 (anti-IL-2R)(Ceredig et al., 1985), thymocytes or lymph node cells were routinely
M1/70 (anti-Mac-I) (Springer et al., 1979) and 53- stained with FITC-anti-CD8, PC-anti-CD4, and PE-
10.1 (Ledbetter et al., 1979) as previously described anti-Thy-l.2, or with another combination using
(Hardy, 1986). Fluorescein (FITC), biotin (bi) or FITC-anti-CD8, PE-anti-CD4, and PC-anti-Thy-l.2,
phycobiliprotein labeling has been described (Hardy, and analyzed with FACS 440. The expression of
1986). CD4 and CD8 in donor-derived cells was examined
by gating on cells positive for donor Thy-1
Cell Preparation and Sorting marker(Thy-l.2 +).
Double-negative thymocytes were prepared from Interleukin Treatment
3-5 week C3H/HeN mice, as previously described
(Muller-Sieburg et al., 1986) by treating with a cock- Human r-IL-6 has been described (Hirano et al.,
tail of antithymocyte antibodies (53-6.7, GK1.5, 53- 1986). Human r-IL-2 was a kind gift of Ajinomoto
7.3), and with MAR18.5 as a facilitating reagent. Co. Ltd., Tokyo. Ten/zg of either r-IL-2 or r-IL-6 in
After treatment with rabbit complement (low-tox-M, 200/l saline were injected intravenously immedi-
Cedarlane, Ontario, Canada), approximately 90% ately after cell transfer. Following days, the same
pure double-negative thymocytes were obtained, amount of interleukins was injected into the perito-84 N. NAKANO, H. KIKUTANI AND T. KISHIMOTO
neal cavity once a day. Control mice were injected
with the same volume of saline.
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